Community/Retail

Submission is based on phase 2 study results evaluating atogepant in adults who met the primary endpoint of a statistically significant reduction from the baseline compared with a placebo.

We spoke with Carlie Traylor, PharmD, of the National Community Pharmacy Association to learn about a fellowship program offered by NCPA and CPESN

Venlafaxine Extended-Release (Effexor XR) is indicated for the treatment of major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder.

Maty's All Natural Acid and Indigestion Relief is an alternative to traditional antacid tablets to relieve indigestion and heartburn.

Suzanne Soliman, PharmD, BCMAS welcomes Sonia T. Oskouei, PharmD, BCMAS, DPLA to discuss biosimilars within the pharmacy industry.

This is the first RSV vaccination candidate to show clinically meaningful and statistically significant efficacy in adults aged 60 years and older.

Amy Cadwallader, PhD, director of Regulatory and Public Policy Development at US Pharmacopeia (USP), discusses how medicine quality and the medicines supply chain can affect antimicrobial resistance (AMR).

The impact of the pandemic on the mental health of health care workers, including pharmacists and pharmacy staff, has been well documented.

Kai Zhao, PhD, director of the Nasal Physiology and Therapeutic Center in the Department of Otolaryngology at Ohio State University College of Medicine, discusses his research investigating the persistence of taste and smell loss among patients who have been infected and reinfected with COVID-19.

Stephanie Mason believes that pharmacists should expect their involvement in glycemic management to increase in the near future.

Hydrogel Burn Pads provide cooling relief for minor burns and absorbs fluid to prevent infection.

Insurers are refusing to cover new, highly effective anti-obesity drugs, but some prescribers are getting around the issue.

Vaxneuvance was approved for an expanded indication by the FDA on June 22, 2022, for active immunization in children 6 weeks of age and older.

This month's OTC product news features contact lenses for astigmatism, supplements, and children's probiotics.

But investigators find that individuals who had shingles that spread to the central nervous system had nearly twice the risk of developing mental deterioration, though it is rare.

Analysis shows that individuals who received treatment within 3 days of symptom onset with tixagevimab and cilgavimab reduced their risk by 88% compared with the placebo.

The Opioid and Naloxone program at North Dakota State University School of Pharmacy aims to make a difference.

Acuvail ophthalmic solution is a nonsteroidal, anti-inflammatory indicated for the treatment of pain and inflammation following cataract surgery.

Arthriten may offer relief from minor arthritis pain.

The survey results come as the ACIP evaluates data to provide guidance for flu vaccines in older adults.

Jardiance shows reduction of 50% compared with dipeptidyl peptidase-4 inhibitors and 30% compared with glucagon-like peptide 1 receptor agonists.

Study results showed that a lower proportion of participants treated with LAGEVRIO had an acute care visit compared with those who received the placebo.

Data show significantly higher geometric mean titer ratios, meeting prespecified endpoints for superiority against the variant.

Kai Zhao, PhD, director of the Nasal Physiology and Therapeutic Center in the Department of Otolaryngology at Ohio State University College of Medicine, discusses how patients who have experienced a loss of taste and smell following COVID-19 infection may be impacted by this symptom for years without realizing it.

Areas of focus include drug discrepancies during transitions of care, polypharmacy, and promotion of self-management.

By maintaining relationships, pharmacists can create a successful practice and pharmaceutical care services will expand.

Vaxneuvance is now indicated for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in individuals 6 weeks of age and older.

Tocilizumab (Actemra) is indicated for treatment of rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, systemic juvenile idiopathic arthritis, and cytokine release syndrome.

Tecnu Rash Relief Spray treats skin irritation caused by sunburn, minor skin irritations, insect bites, and other minor skin issues.

Appropriate screening tools can help identify individuals at increased risk for or with anxiety, depression, and eating disorders.